GlassScriptPhysician profile
Judy Le
NPI 1982228375
$7,423.81
in general payments reported to CMS, 2019-2025
19 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,632 · 2022: $1,427 · 2023: $1,502 · 2024: $1,580 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,364.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,542.44 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Intracept Rf Probe |
| Vertos Medical, INC. | $1,159.89 | 2021-2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $771.89 | 2023-2025 | Belbuca, Xtampza |
| Abbvie INC. | $644.51 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $500.96 | 2022-2025 | Relistor |
| Averitas Pharma INC. | $218.48 | 2023-2025 | Qutenza |
| Stryker Corporation | $109.09 | 2024 | Mild Device Kit |
| Valinor Pharma, LLC | $76.82 | 2024 | Movantik |
| Pfizer INC. | $63.78 | 2023 | |
| Curonix LLC | $58.92 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $49.41 | 2025 | Evoke |
| Allergan, INC. | $43.09 | 2021-2022 | |
| Medtronic, INC. | $40.67 | 2023 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $33.27 | 2025 | |
| Foundation Fusion Solutions, LLC | $32.61 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $24.73 | 2022 | |
| Pacira Therapeutics, INC. | $24.45 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.99 | 2023 | Euflexxa |
| Relievant Medsystems, INC. | $12.81 | 2023 | Intracept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.